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Introduction 
Several means have been employed to estimate the ischemic myocardium and to evaluate 
the e佐ctivenessof myocardial preservation techniques. These include the measuring of amounts 
of intermetabolites during anaerobic glycolytic pathway such as lactate, pyruvate, glucose 
6-phosphate, etc., and the assay of high energy phosphat巴compoundssuch as creatine phosphate 
(CP) and adenosine triphosphate (ATP) from the excised myocardium. An electron micro-
scopic study is also performed as usual. In the previous biochemical and electron microscopical 
studies6•37l, related to the present one, superiority of asanguineous cardioplegia (cold blood 
potassium は rdioplegia (CBKC)) to asanguineous cardioplegia (glucose-insulin potassium 
cardioplegia (GIKC)) for myocardial protection during ischemic arrest was confirmed. じn-
fortunately, however, even with myocardial protection afforded by CBKC, it was impossible to 
prevent completely a reduction in high energy phosphates or destruction of cellular structureas1 
of the ischemic myocardial cels when periods of ischemia extended. Furthermore, the previous 
study,6l using polarography to measure the level of oxygen tension within the myocardium, 
confirmed that, during intermittent CBKC、thelevel of oxygen tension in the myocardium, 
which at first fel of dramatically, began to climb again when the period of ischemia reached 
150 minutes. At the same time‘when oxidation』reductionreaction :¥AD＋ご:'.¥TADHwas 
measured by means of microfluorometry, it was possible to ascertain that transformations in the 
direction of either oxidation (Ni¥_D+) or reduction (NADH) had ceased and remained suspended 
even with further infusion of the cardioplegic solution. It seems reasonable to interpret this 
phenomenon as a condition in which, as the result of the near cessation of oxidation-reduction 
reaction in the mitochondria, oxygen is no longer being reduced: the process of electron transport 
has been disrupted. What precisely, then, is the area of the electron trnasport chain where this 
disruption takes place? 
Coenzyme Qio (CoQ10) is a component of the process of electron transport; it is held to be 
the only component which can move freely in the inner membrane of mitochondria. The research 
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described in this paper h社、 takenthis characteristic of （、o<)as a point of departure; it examines 
what variation occurs in the level of myocardial CoQ10 with prolonged ischemia, and considers 
what the significance of the:,e variation may be. In addition司thisstudy investigates whether or 
not lipid peroxide is in fact produced during ischemiaぅandalso what variation occurs in the 
amount of vitamin E (YE). which is held to be an antioxida川、 presentin the myocardium. 
Meterials and Methods 
In thi, serie、ofexperiments six mongrel dogs weighing 12 17 kilograms were used. They 
were anesthesized by intravenous injection of 25 mg/kg of pentobarbital sodium. In each case, 
a dog w川 placedunder intermittent positive pressure breathing by a Harvard respirator. The 
thoracic cavity was opened by a bilateral incision in the fourth intercostal space. After an 
intravenous injection of 3 mg/kg heparin‘cannulation for the transmission of blood into the body 
and for removing blood from the body was performed into the right common carotid artery and 
into the right atrium respectively, and extracorporeal circulation was begun with non blood 
primeはta final hematocrit of 25 30° 0. Bubble oxygenators，刈τhas Temptrol Q130 manu-
factured hv Bentley Laboratories or those made by Japan l¥ledical Supply Cc., Ltd. were used 
in these experiments. Blood w山 sentback to the body at a rate of 80 ml/kg/min by means of 
a roller pump made by ~a rns Inc.. After core cooling to the point where the esophageal 
temperature reached 32コぐ． the ascending aorta was cross clamped and 20-30 ml of diluted 
potassium chloride solution (150←200 mEq/1）ぅ cooledto 4°仁lwas immediately injected manually 
into the aortic root so as to arrest the heart in diastole. Topical cardiac cooling was employed 
simultaneously. (・a re was taken to ensure that the myocardial temperature, as measured at the 
apex of the heart by a thermistor probe, did not subsequently exceed 15 C At this point, extra-
corporeal circulation was stopped and the blood was drawn off into the oxygenator so that it could 
be used in the CB K solution. Immediately after achieving diastolic cardiac a rrcsιthe五rst
specimen of the myocardium was removed from the apex of the left ventricle. Each tisue 
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specimen was divided into its outer and inner layers and then used for measurements of levels of 
VE and CoQ10 in the myocardium. Subsequently, 10 ml/kg of either GIK or CBK solution, 
the composition of which is shown in Table 1, was infused every 30 minutes by gravity. During 
this procedure, specimens of myocardial tissue were taken every 60 minutes until the period of 
ischemia reached 180 minutes. In parallel experiments, when the method of cardiac protection 
described above were employed on other mongrel dogs, about ten gram of tissue each was excised 
from the apex of the left ventricle, and the mitochondria was removed from each of these speci-
mens according to TYLER47> method. Measurements were taken of the amounts of lipid 
peroxide (in this paper tribarbituric acid reactive substance (TEARS) was measured as the 
representative of lipid peroxide) and CoQ10 in the mitochondria, the method followed being that 
of P ACKERa4> for the former measurements and that of ABE and associates1> for the latter. Values 
for TEARS and CoQ10 were expressed in terms of the levels of proteins in the mitochondria as 
measured by the procedure of LO¥¥'RY and associates23> The amounts of CoQ10 in the 
myocardium were measured by means of high performance liquid chromatography (HPLC) 
under conditions for analysis proposed by ABE and associates!). :¥Ieasurements of the amounts 
of myocardial VE were also carried out with the aid of HPLC under analytical conditions propos-
posed by KATO and associates;18> the specimens of myocardial tissue were prepared before 
measurement according to the method developed by ABE and associates2> 
Values were expressed as a mean土standarderror （：＼！土SE). Statistical analysis was per-
formed by means of Student t test, with P<0.05 considered significant. 
Results 
1. Variations in the level of TBARS present in the mitochondria (Fig. 1) 
TBARS in the mitochondria was found to be 0.27 n moles/mg prot. (for the following figures 
the un山 ofmeasurement will be omitted) just after the aorta had been clamped o任 Asthe 
period of ischemia continued, this value increased: after 60, 120, and 180 minutes, the values 
obtained were 0.39土0.06,0.63土0.18,and 0.67土0.15,respectively, for the GIK group and 
0.49土0.04,0.66土0.06,and 0.65土0.12,respectively. for the CBK group. In the case of the 
GIK group, the deviation was so great that no significant change could be confirmed, but in the 
CBK group the values obtained after ischemia had lasted 180 minutes were high enough to be 
considered significant when compared with the values measured immediately after the aorta had 
been clamped of. Unfortunately, a significant difference between the two groups could not be 
recognized. 
2. Variations in the level of CoQ10 in the mitochondria (Fig. 2) 
Immediately after the aorta was clamped shut, CoQ10 was measured in the mitochondria at 
a level of 13.8土0.07μ.g/mg prot. (for the following figures the units of measurement will be 
omitted). As the period of ischemia progressed, there was a tendency for this value to decline: 
after 60, 120, and 180 minutes, the values obtained were 12.8土1.0,11.9士0.5,and 7.5土0.5,
respectively, for the GIK group. As these results show, the value obtained辻t180 minutes 
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Fi邑.1. Change・' in TEARS in mitochondria are shown. The TBARS values are 
significantly increased beyond 60 minutes after aortic clamping, but there 
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represents only 55% of the value measured just after the aorta was cross-clamped. In the case 
of the CBK group, the corresponding values were 14.0士1.5,13.6士1.3,and 9.5土1.3--here,too, 
after 180 minutes there has been a decrease. in this case to 69% of the value seer 山 tafter a clamp 
was placed on the aorta. Values for the CBK group remained constantly higher than those of 
the GIK group, but not to a degree which could de命1itelybe considered significant. 
3. Variations in the level of myocardial CoQ10 (Fig. 3, Table 2 Table 3) 
Fig. 3 presents the chromatograms obtained as CoQ was measured. CoQ9 as well as 
CoQ10 is indicated in this case, but the retention time of CoQ10 is short only 11 minutes. Table 
2 gives a chronological list of changes in the amount of myocardial CoQ10 recorded when the 
myocardium was protected by GIKぐ Valuesof CoQ10 obtained for the outer layer of the 
myocardium at the onset of ischemia, and then as ischemia reached the 60-, 120 , and 180-
minute marks, were 440土60μ.g/gww (units of measurement omitted in the following figures), 
439土61,367士49,and 330土48,respectively; corresponding values for the inner layer of the 
myocardium equaled 465土66,379士46,325土42,and 262土36at the same points in time. Both 
the inner and outer layers of the myocardium showed a decrease in CoQ10 values with the passage 
of time司 butthe rate of decrease in the inner myocardial layer was striking: after 60 minutes of 
ischemia, a statistically signi五rantdecrease had already occurred, the figure having dropped to 
83% of the value recorded just after the aorta was cross-clamped. This decline continued 
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Fi邑・3. Chromatograms of CoQ10 in the myocardium obtained from two dogs. CoQ9 
as wel as CoQ,0 was indicated in the second case. ー
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Table 2. C川J11values in the myocardium protected by glucose-insulim-potassium cardioplegia. 
Subepicardium Subendocardium 一 Time after aortic clamping ( minutes ) 
No. 。 60 120 180 。 60 120 180 
1 2 4 0 200 1 3 7 I 4 0 238 1 9 0 1 2 8 1 1 2 
2 6 8 8 5 6 8 4 3 0 4 2 5 7 0 6 53 4 1 1 3 1 4 
3 4 4 7 4 9 2 3 7 1 2 9 3 4 06 3 6 5 3 1 7 2 3 9. 
4 4 2 7 5 2 6 4 8 5 4 7 5 536 4 4 6 4 3 5 401 
5 299 266 309 2 3 3 3 I 0 290 2 7 4 2 4 1 
6 5 3 7 580 4 7 1 4 1 6 5 9 5 4 4 5 382 267 
M+SE 440←60 439士61 367149 330 1-48・465 I 66 379::146本 325+42. 262士36・
事 Pく 0.05 
Per cmt change in CoQ1o value of the ischemic myocardium protected by glucose-insulin-
potassium cardioplegia. 
Subepicard1um Subendocardium 
Time after aortic clamping (minutes ) 
No. 。 60 120 180 。 60 120 180 
1 1 0 0 83 57 58 1 0 0 80 54 4 7 
2 1 0 0 8 3 6 3 62 1 0 0 76 58 4 4 
3 1 0 0 1 1 0 8 3 66 1 0 0 90 7 8 5 9 
4 I 0 0 1 2 3 1 1 4 I 1 1 1 0 0 8 3 8 1 7 5 
5 1 0 0 89 1 0 3 7 8 1 0 0 9 4 88 7 7 
6 1 0 0 1 0 8 88 7 7 I 0 0 7 5 64 4 5 
M士SE 1 0 0 99士6 85士8 75十7 1 0 0 83+3 71士5 58土6
Signi品cantdecrease is found in the subepicardium at 180 minutes of the ischemic time and 
in the subendocardium after 60 up to 180 minutes of aortic clamping. 
There is no signi品cantdifference between both la：でrs
first value. In the case of the outer layer of the myocardium, on the other hand, the decline in 
ぐo<}lovalues remained relativeh・ ;,mall: at the point the duration of ischemia had reached 
180 minutes. the vはJueof （、o<J1 o had only declined to 75° 0 of the original value. Table 3 indicates 
variations in the amount of CoQ10 in the myocardium during myocardial protection by means of 
仁BKC. With this method, a decrease over time is again evident for both the inner and outer 
layers of the myocardiumぅbutit is slight in comparison with the figures for c; I t札、 Whenthe 
period of isdwrnia had reached 180 minutes, the value of CoQ10 for the outer layer of the myo・
cardium w出 89ちbof the first value recorded. and 74°0 in the case of the inner !aver in other 
wonk the decrc;1、t’was15°.υless than that observed with CIKC. 
4. ¥'ari;1tions of ¥'E in the myocardium (Fi日 4,Table 4, Table 5) 
h日 4depicts the conditions for the analysis of I’E and gives the chromato広ram. Each 
homolo宮ueof YE isckarlv叱 l川 rate! and in di ca ted; the retention time of these homologues l見
short onlv 9 minutes. Ch孔11伊、 over time in the values of myocardial αtocopherol 
(a tocopherol w川 chosento represent ¥'E becasue it is the most activぞ biochemicallyof the 
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Table 3. CoQ10 values in the myocardium protected by cold blood potassium cardioplegia. 
Subepicardium Subendocardium 
Time after aortic clamping ( mrnutes ) 
N:l 。 60 120 180 。 60 I 2 0 I 8 0 
1 746 878 689 6 4 1 656 665 4 8 I 3 9 3 
2 332 269 304 387 3 2 5 309 256 3 4 0 
3 635 505 7 1 2 5 4 9 790 6 5 8 6 7 4 5 2 8 
4 308 268 2 3 4 224 298 2 6 I 2 1 4 2 1 2 
5 363 357 3 3 7 3 2 3 3 7 8 3 4 5 3 2 4 92
6 429 3 9 1 375 3 4 7 4 5 3 4 0 6 3 1 3 288 
世てSE 469 lc67 445す：86 442+77 412158 483174 441166 377寸：64**342+41事
事 Pく0.05 帥 p< 0.0 0 5 
Per cent change in CoQ1o value of the ischemic myocardium protected by cold blood 
potassium cardioplegia 
Subepicardi um Subendocardium 
Time after aortic clamping (minutes ) 
N:l 。 60 120 180 。 60 120 180 
1 1 0 0 1 1 8 92 86 1 0 0 1 0 1 73 60 
2 1 0 0 8 1 92 1 1 7 1 0 0 9 5 7 9 1 0 5 
3 1 0 0 9 4 1 1 2 86 1 0 0 8 3 8 5 6 7 
4 1 0 0 87 76 7 3 1 0 0 8 8 7 2 7 1 
5 1 0 0 9 8 9 3 89 1 0 0 9 1 86 77 
6 1 0 0 9 1 8 7 8 1 1 0 0 9 0 69 64 
M±SE 1 0 0 95+5 92士4 89士6 1 0 0 91±2 77士3 74士6
It is noted that CoQ10 values in the subendocardium are signi五cantlydecreased at 120 and 
180 minutes after aortic clamping, but there is no signi凸cantdifference between the subepi-
cardium and subendocardium at each ischemic time. 
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homologues) are shown during protection of the myocardium by GIK or CBK cardioplegia in 
Tables 4 and 5, respectively. In the case of GIK＜人 asischemia continued for 60, 120, and 
180 minutes, the values at these points in time for the outer layer of the myocardium were 
16.5 μ.g/gww (units of measurement omitted in the following figures), 15.2土2.2.and 15.1土2.2、
while the corresponding values for the inner layer of the myocardium equaled 15.2土2.0,14.0土
2.0, and 13.6士2.2-ineither case. hardly any change took place. Results with CBl-¥.C. at the 
points in time mentioned above, were 17. 0土4.3、17.3土4.5,and 16.3土3.6for the outer layer 
of the myocardium, and 16.0士3.9,16.9士4.7,and 16.8土4.7for the inner layer. Again, there 
was practically no change discernible. 
Discussion 
Normally, the mammalian myocardium metabolizes through aerobic pathways、utilizing
al substances as fuels. These include free fatty acids. glucose, ketones‘lactate, pyruvate司 etc.
These substances ultimately transferred to the mitochondria, where the electron energy is released 
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Fig. 4. HPLC analysis of tocopherols in the myocardium. Each homologue of vitamin 
E iswel separated and indicated in the chromatogram. 
through the T＜λcycle and the respiratory enzyme chain. Such energy is trapped in orderly 
fashon and ultimately incorporated into ATP. The mitochondria comprise almost 40 to 50~0 
of the average mammalian myocardium. The electron transport system is very active in the 
heart mitochondria. It is suspected that the mitochondria produce active oxygen species such 
as superoxide anion （・02一）， hydrogen peroxide (H2< H、andhydroxy radical (HO・） during 
oxidative metabolism4>. These oxygen species are very reactive and moreover cytotoxic. 
Living organism are kept from the attack from these active oxygen radicals by metabolizing 
them to non toxic chemical substances such as water and molecular oxygen. 
By the way, it is generally recognized that, with the onset of ischemia, the level of CP and 
ATP in the myocardium falls off rapidly5•16'17>. It is also well known that, if ishcemia is pro・ 
longed, the cellular structure disintegratesio.11.40> Exactly, what processes take place in the 
interior of the cel to produce such an outcome? 
Since the supply both of oxygen and of energy substrates ceases when the myocardium 
experiences i引 hernia‘theoxygen density in the vicinity of the mitochondria、whichnaturally 
has a low oxygen tension to begin with‘falls even lower. Would any kinds of radicals be gener・ 
ated also in ischemiaコ
DMIりpけじLOS8> has proposed the following hypothesis: since during ischemia there is a 
shortaεe of oxygen to serve as an acceptor of electrons, a surplus of electrons builds up in the 
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Table 4.α tーocopherolvalue of the ischemic myocardium protected by glucose-insulin-
potassium cardioplegia 
Subepicardi um Subendocardium 
Time after aortic clamping ( minutes ) 
l'≪i 。 60 120 180 。 60 120 180 
1 2 2.6 2 I.5 1 8.4 I 5.2 2 2.5 1 6.4 I 4.0 12.7 
2 1 3.4 1 2.9 1 1.0 1 4.2 1 3.0 I 2.3 I I.2 I 1. 7 
3 1 2.0 1 3.1 1 2.4 1 2.9 I I.8 I 3.0 I 2.4 I l.8 
4 2 8.5 2 5.1 2 5.8 2 6.6 2 9.4 2 5.8 2 4.5 2 5.4 
5 1 2.7 I 3.3 1 2.5 1 I.9 I 2 4 I 2.6 I l.7 I 0. 6 
6 1 l.3 1 3.0 1 0.8 9.7 1 I.8 I 1. 2 1 0.4 9.1 
M士SE 16.8士2.6 16.5士2.0 1 5.2士2.2 1 5.1士2.2 16.8+2.8 1 5.2士2.0 1 4.0±2.0 I 3.6土2.2
Per cent change inα tーocopherolvalue of the ischemic myocardium protected by glucose-
insulin-potassium cardioplegia. 
Subepicardium Subendocardium 
Time after aortic clamping (minutes ) 
l'≪i 。 60 120 180 。 60 120 180 
1 1 0 0 9 5 8 I 6 7 I 0 0 7 3 6 2 56
2 1 0 0 96 82 1 0 6 1 0 0 9 5 86 90 
3 1 0 0 I 0 9 10 3 1 0 8 I 0 0 I10 I 0 5 1 0 0 
4 1 0 0 88 9 1 9 3 I 0 0 88 83 86 
5 1 0 0 1 0 5 98 9 4 I 0 0 1 0 2 94 8 5 
6 1 0 0 1 1 5 96 86 I 0 0 9 5 88 7 7 
M士SE 100 101二片4 92士3 92+6 1 0 0 94士5 86士5 82士6
There is no significant difference. 
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electron transport system and radicals of CoQ10 and flavin adenine dinucleotide (FAD) are form-
ed; the polyunsaturated fatty acids of the cell lipids become acceptors of the CoQ10 and FAD 
radicals; a hydrogen atom is then abstracted from the vicinity of the double bond and alkyl 
radicals are formed. Since the unsaturated fatty acid radicals, which are unstable and highly 
reactive, react easily with the small quantity of ground state oxygen which exists in the mito-
chondria, a peroxidation chain reaction is initiated inside the membrane, with the result that such 
lipid peroxides as hyroperoxide and endoperoxide are produced and the chain reaction comes 
to an end, but not before the structure and functions of the membrane suffer damage. The results 
of th巴experimentsdescribed in the present paper lend support to DEMOPOULOS’hypothesis, for 
they indicate that TBARS is produced in the ischemic mitochondria. KocuRE19・20>, however, 
holds that lipid peroxides are not formed during ischemiaぅbutrather when blood and oxygen 
are again supplied to the cells which have experienced ischemia, i.e. lipid peroxides are formed, 
in KoGURE's view, at the time of reperfusion (post-ischemic peroxidation). 
According to KoGURE and associates21＞、 thepathological series of biochemical changes 
covered by brain ischemia can be classified into three phases. In the first phase, glycolysis in 
the cytoplasm is restricted, but there is as yet no disruption of the electron transport system. 
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Table S. a-tocopherol 、はluピofthe ischemic myocardium protected by cold potasium 
blood cardioplegia 
Subepicardium Subendocardium 
Time after aortic clamping (minutes ) 
l'≪i 。 60 120 180 。 60 120 180 
1 9. 7 8. 5 1 I.2 1 I.1 1 0.5 9.9 1 0.8 1 0.5 
2 3 7.7 3 8.9 4 1.1 3 5.8 3 9.0 3 6.2 4 I.7 4 I.7 
3 7.4 8.3 7.2 8.9 7.9 7.5 7.5 7.4 
4 1 6.3 1 8.8 1 6.6 1 6.8 1 7.0 1 6.5 1 6.9 1 7.4 
5 1 3.3 1 3.1 1 3.5 1 2.7 1 I.5 1 I.2 1 0.9 1 0.1 
6 1 5. 4 1 4.3 1 4.0 1 4.2 1 5.8 1 4.6 1 3.8 1 3.5 
祉士SE 1 6.6-1 4.0 1 7.0士4.3 1 7.3士4.5 16.6+3.6 1 7.0+4.2 16.0士3.9 16.9±4.7 16.8士4.7
Iヘr《叩tchange in a-tocopherol of the ischemic myocardium protected by cold blood 
potassium cardioplegia. 
Subepicardium Subendocardium 
Time after aortic clamping (minutes ) 
l'≪i 。 60 120 180 。 60 120 180 
1 100 88 I 1 5 I I 4 1 0 0 94 1 0 3 I 0 0 
2 100 1 0 3 1 0 9 9 5 100 9 3 1 0 7 1 0 7 
3 1 0 0 1 1 2 97 1 2 0 I 0 0 9 5 95 9 4 
4 I 0 0 1 1 5 1 0 2 1 0 3 1 0 0 9 7 99 1 0 2 
5 1 0 0 9 8 1 0 2 9 4 1 0 0 97 9 5 88 
6 1 0 0 9 3 9 1 9 2 1 0 0 9 2 87 8 5 
MすでSE 1 0 0 102±4 1 0 3士3 10314 I 0 0 95+1 98+3 96±3 
r¥o sigm五cantdiference is found. 
Within this period, ifblood flow is restored, NADH within the cytoplasm would be oxidized by 
means of the shuttle system and the electron transport system in the mitochondria and become 
~AD~－ The oxidation of substrates would recommence smoothly and、sinceelectrons could 
then be transferred to the oxygen molecules in su伍cientquantitites through the electron transport 
system, it can be supposed that pr；ιH.'ticaly no active oxygen would be generated. In the second 
phase, glycolysis in the cytoplasm comes almost to <1 standstill, but the electron transport system 
stil remains intact. Within this period, even if blood flow is restored, itwould not be possible 
to oxidize .'¥AI>H in the cytoplasm, since the shuttle srtem would not function; accordingly, 
with no electrons flowing in the elctron transport system of the mitochondria‘oxygen within 
the mitochondria could only be partialy reduced, and such types of active oxygen as・0ιH202・
and HO・wouldbe generated. In the third phase, the electron transport system in the mito・ 
chondria isdamaged so that even if blood flow is restored and oxygen is again provided, no
reduction of oxygen takes place because electrons are not being transported. Koc URE states, 
moreover, that if one can assume that peroxidation of lipids takes place owing to radicals lacking 
one l'lectron which have come loose from the 仁、l引 trontransport system in accordance with the 
mechanism postulated by fJi..Mfll川 ¥JU＞メ、 thenthis peroxidation j, part of the third phase of the 
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pathological series of biochemical changes subsumed by the term ischemia. 
CBK cardioplegia is a method of myocardial protection which intermittently resupplies 
oxygen to the myocardial cells undergoing ischemia. Results of the experiments presented in 
this paper make clear that, with this method, TEARS does increase as the period of ischemia is 
prolonged. On the basis of these experiments, however, it cannot be asserted that with this 
method production of TEARS definitely occurs to a greater extent than in the case of GIK 
cardioplegia, which povides almost no supply of oxygen. In sum, resultとも which would lend 
positive support to KoGURE’s views were not forthcoming in the experiments presented here. 
This outcome may possibly be due to suppression of TEARS production resulting from the 
profound low myocardial temperature incidental to CBKC and GIKC, or it may be due to the 
di伍cultyof properly comparing the results here with KoGURE’s since the experimental models 
were completely different. At any rate, there in no question as to the fact that lipid peroxides are 
generated inside cells once they have fallen into a state of ischemia. Lipid peroxides are known 
to cause cleavage of the polymerized polypeptides and also chemical changes in amino acids ;35•36> 
the importance of preventing the formation of lipid peroxides is readily understandable in view 
of the damage they cause to subcellular organelles2s.4s). 
Coenzyme Q (CoQ) was discovered by MooRE and colleagues31> in 1940; in 1957 CRANE 
and associates7l isolated it from lipids in beef heart mitochondria. It is now known to exist 
widely in almost al living organisms. Its basic molecular structure is 2,3-dimethoxy-5-methyl-
1,4-benzoquinone with an isoprenoid side chain at C-6 (Fig. 5). CoQ9 occurs in mammals to-
gether with CoQ10, but in man this coenzyme is present only in the form CoQ1022>. CoQ, 
which in the electron transport system intermediates betwe~n the flavoprotein and cytochrome 
chains, is believed to function as a coenzyme promoting the production of ATP. 
According to M1cHELL, protons inside the inner membrane of the mitochondria are shifted 
to a position just inside its outer wall, where they increase the proton density; when the protons 
along the outer wall, with the help of A TPase, move to the inner wall of the inner m巴mbrane,
ATPase is a「tivatedand the synthesis of ATP results. エIICHELLtakes the view that, as part of 
this mechanism, CoQ moves about freely in the inner mitochondrial membrane, transporting 
protons to both sides of the membrane (proton motive Q cycle)29,3oi. 
Given this interpretation of the function of CoQ, it is logical to suppose that, if CoQ W巴re
to be adversely affected in any way, then at that point production of ATP would cease. In the 
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Fig. 5. Molecular structure of CoQ 
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course of the research described here, measurements of the amounts of CoQ10 in the myocardial 
cels made during myocardial protection by either GIKC or CBKぐdemonstrated,first, that with 
either method the levels of （‘0Q10 decreased with time; second, that this decrease was smaller 
in the case of CBKC than with GI!:(('; and thirdly, that the percentage of decrease was greater 
in the inner myocardial layer than in the outer. Here it may be noted that both Y AMASAwA49J 
and "'AMA GA Ml；へ withtheir respective colleagues, have con日rmed,as a result of inducing 
cardiac infarction experimentally, that the l巴velof CoQI() in the affected areas of the myocardium 
W川 quitelow compared with the una仔ectedareas; this observation agrees with the results obtained 
from the experimental model described here, which involved global ischemia. 
How, then, is this deてre山 ein CoQ10 to be interpreted? CoQ10 is not a vitamin, though it
functions like one39> Unlike a vitamin, it is synthesized within the living organism from such 
materials as tyrosine, phenylalanine, and various vitamins and minerals. In ischemic myo・
cardial cels, it may be assumed that, since substrates for the synthesis of CoQ10 are not being 
supplied, there is no production of CoQ10 going on. This b巴ingthe case, the fact that CoQ10 
decreases suggests that Co<J 10 isbeing consumed. Quite possibly cleavage of the isoprenoid 
side C'hain takes place, ~o that a transformation results either into some types of CoQ other than 
CoQ9 and CoQ10, or into a different chemiιal substance. While the reason why it was possible 
to maintain a higher level of Co<J 10 with CB KC than with GIKC is not clear, itmay be that the 
constituents of the blood include substances from which CoQ10 is synthesized. Furthermore, 
the somewhat larger decrease in the amounts of CoQ10 observed in the inner myocardial layer 
in t、：omparisonwith the outer layer ~uggests that there is a difference in the metabolism of CoQ10 
between these two muscle layers 
It has been reported that CoQ10 has an inhibiting effect on the formation oflipid peroxides21>. 
Accordingly, on the a、sumptionthat exogenous CoQ10 would be absorbed into the myocardial 
celメifadministered, itis logical to suppose that it would inhibit the production of lipid peroxides 
which are thought to be generated during ischemia or reperfusion、andthereby make it possible 
to protect the functions and structure of the myocardial cells during ischemia or reperfusion. 
Fortunately it has been demonstrated that CoQ10 administered as a drug is incorporated into the 
inner membrane of the mitochondria;32> furthermore, ABE and associates3>, MATSUNAGA and 
as,oC'iates25>, and TAKEUCHI and川 sociates4> administered CoQ 1 0 either into a vein or, along 
with the protective solution for the myocardium, into a coronarv artery, and al reported suces 
in alleviating a decrease in high-energy phosphate compounds. Furthermore, TANAKA and 
associates43> confirm the effectivenes of CoQ10 for clinical use. Having administered ぐ0Q1oorally
to patients scheduled to undergo surgery for valvular dise山崎、 thevfound that, after valve re-
placement surgery, the group which had received CoQ10 showed a lower incidence of low cardiac 
output syndrome than the control group. Opinion remains divided, however. on the methods of 
administering CoQ10 and on the dosage, topics which should receive careful consideration in the 
future. 
VE was first discovered as anはnti-infertilityvitamin by EvANS and BISHOP in 1922; since 
then、itshomologuれ h《J¥'ebeen named a-, {3－，γ，a吋 Stocopherol in the order of their efectivenes 
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in combating infertility. Their molecular structure are shown in the Figure 6. While the role 
of VE in metabolism is stil not entirely understood, it is generally recognized to have an anti-
oxidant effect. Among the more important observations upon which this conclusion is based 
are the following: 1) VE prevents the oxidation of such substances as unsaturated fatty acids and 
vitamin A; 2) certain other antioxidants are effective as substitutes for VE in some types of VE 
deficiency ;12> 3) the amount of lipid peroxides increases in animals suffering from VE 
deficiency;42> 4) when VE isadministered to animals, the amount of lipid peroxides in the liver 
cels decreases 24>. 
VE isone of the vitamins which are soluble in lipids. In the blood stream it is bonded to 
~－Iipoprotein; in the cell membrane it is bonded to this lipoprotein and forms part of the cell 
membraneaa>. VE isthought to contribute to the stability of the cell membrane by eliminating 
active oxygen species and unsaturated fatty acid radicals and preventing thereby the formation 
of lipid peroxides1ゐ28ぺs>(Fig. 7). 
As far as the results of the present experiments are concerned, it was not possible to confirm 
changes over time in the amount of αーtocopherolpresent in the myocardium during either CBKC 
or GIKC. In view of the fact the VE makes up part of the cell membrane, as was stated above, 
it was expected that a decrease in VE would take place about 150 minutes after the onset of 
ischemia, the time when the morphological disintegration of the cell membrane is observed, but 
such a decrease was not evident for reasons which are not clear. 
VE and CoQ are similar in their chemical structures, but as part of the biochemical reactions 
which sustain life they perform completely different functions. VE isa chromanol; the quinone 
analogue of VE corresponding to CoQ is plastoquinone. This substance does not work like VE 
nutritionally, but is involved in photosynthesis. CoQ, on the other hand, is a quinone; chromanol 
of CoQ which corresponds to VE evinces no sort of biological activity. FoLKERs13> has establish-
ed that VE cannot take the place of CoQ in the function of coenzyme. He also states that: 1) 
in human beings, deficiency in VE causes widespread damage to lipids, including damage to 
OH 
R R1 
R = ( CH2CH2CH2CH2~：~ ,cH, 
-Tocopherol R1 R, R, 
a-tocopherol CH, CH, CH, 
β・t町opherol CH, H CH, 
:r-tocopherol H CH, CH, 
8-tocopherol H H CH, 



















RO・ lipid peroxide fre radical 
Fi邑.7. Chemical reaction betweenα tーocopheroland a lipid peroxide free radical is shown. 
a-tocopherolquinonc, a quinone form of αーtocopherol,is formed as a result of oxida-
tion ofα tーocopherolby the radical, which is reduced to a fatty acid. 
CoQ and （‘o<J precursors‘as a result of oxidation; 2) when VE deficiency is not accompanied 
by impairment of CoQ biosynth引 is.the situation can be corrected by administering VE, which 
not only prevents the disintegration of CoQ and its precursors, but also eliminates damage stem-
ming even from extensive lipid peroxidation; 3) if biosynthesis of CoQ is disrupted, a de五ciency
of VE intensifies the de五ciencyof CoQ and its precursors in VE de五cientpatients by admin-
istering VE in medicative dos且ge,CoQ is not fully restored in cases where biosynthesis of CoQ 
has been吋 riou、lyimpaired. 
EDWIN and a州 oci川es"'have reported that myocardial CoQ decreases in animals suffering 
VJ七deficiencv,and similar results were obtained in research with VE deficient hamsters conducted 
by the present author (Table 6). Such observations support the view that there is a close relation-
ship between V l・； and（正バ］ ト-iUGIYAMAand associ乱tes41>state that in suppressing the formation 
of lipid peroxides CoQ10 has the greater effect in the myocardium, but in the liver VE ismore 
Table 6. Changes in the amounts of serum a-tocopherol, myocardial a tocopherol, and 
myocardial ( o<Jio of hamster' fed on either VE de五cientor VE contained diets. 
α－t叫 0凶官ol ina-~目y偲。同a町rdi':1rn in C閣m官y”皿1:.-d~・n m serum 
(μg/ml) (μg/g.w.w.) (μg/g.w.w.) 
Group I 0.40士0.08 ND 3.8土5.3
Group I 20.5士4.5 17.3土5.3 43.0土4.8
Groupm 9.2土1.2 3.1士2.3 46.5土4.4
Each value is expressed as mean土SJ>
Group I: ！＂引lon九区 deticicnt diet (corn oil added) (n =6) 
Group I: fed on VE added diet (corn oil added) (n二 6¥
Group I l: fed on VE normal diet （仁川noil added) (n=6) 
ND: not detected 
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effective. Accordingly, the results of the experiments described in the present paper could be 
interpreted to mean that CoQ10, in producing a greater suppressive effect on the formation of 
lipid peroxides in the myocardium, was consumed to a greater degree than VE. 
In reporting on their work with rabbits, however‘GUARNIERI and colleagues15> ,tate that, 
by administering VE、itproved possible: 1) to preserve mitochondrial function in hypoxic 
perfused rabbit heart muscle; 2) to limit the decrease in high-energy phosphat巴 compounds;
3) to prevent reoxygenation injury at the time of reoxygenation. On the basis of these results, 
it may be suggested that, like CoQ10, VE would be an effective drug for use in myocardial pro-
tection, provided that it can be incorporated into the myocardial cells when administered. (In 
research not yet published, the author of the present paper discovered that levels of αーtocopherol
in the right atrial appendage approximately trebled as a result of the administration, orally, of 
αtocopherol nicotinate.) 
Summary 
When ischemia of the myocardium was induced by occlusion of the aorta, and myocardial 
protection was carried out by means of either cold blood potassium cardioplegia or glucose-
insulin-potassium cardioplegia, the following observations were made: 
1. It was possible to confirm that an increase over time took place in lipid peroxides in the 
mitochondria of the myocardium. It could not, however, be definitely concluded that 
the formation of lipid peroxides was greater in the case of CBKC than in the case of 
GIKC. 
2. A decrease over time was recognized in levels of CoQ10 in the myocardium and in the 
mitochondria. This decrease was especially marked in the case of GIKC, and was more 
conspicuous in the inner myocardial layer than in th巴outer.
3. The amount of VE in the myocardium showed almost no change. 
From these results, it might be concluded that the formation of lipid peroxides and thereby 
the depletion of CoQ10 in the myocardium, especially in the inner myocardial layer, play an 
signi五cantrole to produce cellular damages caused by ischemia of the myocardium. 
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レアチン燐酸 tCPJやアデノシン3燐酸 tATP）が急 CBKC、が GIKClと比して過酸化脂質の生成が多いと
也lζ減少する．もし，虚血が長時間に及べは司細胞機 は必ずしも言えず，低温によって過酸化脂質の生成が
能の低下や細胞構築の崩壊を余儀なくされる． 抑制される可能性があることを示唆していた．






カリウムから成る GIKcardioplegia ¥C;IKCJを，ま という点では CBKCは GIKC、よりも優れているこ
た血液そのものを用い， coldblood potassium cardio- とを示唆していた
plegia (CBK引をおとない，虚血心筋細胞内の過酸 3) 両法とも，心筋内 VE含量にはほとんど変化が
化脂質，コエンザイム Q10rc,,Q,,,j.ビタミンE(VE) 認められなかった．とり~，，＇；訪日－；：，同じく遊離基消去物
の含量を測定し，それらの経時的変化を検討したとこ 質でありながら CoQ10と VEの消耗度は臓器ICょっ
ろ，以下の結果が得られた． て異なり，心筋においては CoQ10の方が消耗が大き
1) ミトコンドリア内の過酸化脂質は両法ともに経 く，より強い抗酸化作用を発揮していることを示唆し
時的に増加し，虚血180分後には虚血直後値の 2倍以 ていた．
